DESFLURANE LIQUID

Ország: Kanada

Nyelv: angol

Forrás: Health Canada

Aktív összetevők:

DESFLURANE

Beszerezhető a:

BLUE-ZONE TECHNOLOGIES LTD

ATC-kód:

N01AB07

INN (nemzetközi neve):

DESFLURANE

Adagolás:

100%

Gyógyszerészeti forma:

LIQUID

Összetétel:

DESFLURANE 100%

Az alkalmazás módja:

INHALATION

db csomag:

100

Recept típusa:

Prescription

Terápiás terület:

INHALATION ANESTHETICS

Termék összefoglaló:

Active ingredient group (AIG) number: 0128744001; AHFS:

Engedélyezési státusz:

APPROVED

Engedély dátuma:

2020-04-17

Termékjellemzők

_ _
_DESFLURANE (desflurane, USP)_
_ _
_ _
_ _
_ _
_ _
_ _
_Page _
1
_ of _
47
_ _
PRODUCT MONOGRAPH
PR
DESFLURANE
(desflurane, USP) 100% v/v
Liquid for Inhalation
Inhalation Anesthetic
Blue-Zone Technologies Ltd.
Concord, ON
Canada L4K 3C1
Date of Preparation:
April 16, 2020
SUBMISSION CONTROL NO: 199804
_ _
_DESFLURANE (desflurane, USP)_
_ _
_ _
_ _
_ _
_ _
_ _
_Page _
2
_ of _
47
_ _
TABLE OF CONTENTS
PRODUCT MONOGRAPH
.........................................................................................................1
TABLE OF CONTENTS
..............................................................................................................2
PART I: HEALTH PROFESSIONAL INFORMATION
..........................................................3
SUMMARY PRODUCT INFORMATION
..........................................................................................................
3
INDICATIONS AND CLINICAL
USE.................................................................................................................
3
CONTRAINDICATIONS
......................................................................................................................................
4
WARNINGS AND PRECAUTIONS
.....................................................................................................................
4
ADVERSE REACTIONS
.....................................................................................................................................
11
DRUG INTERACTIONS
.....................................................................................................................................
16
DOSAGE AND ADMINISTRATION
.................................................................................................................
18
OVERDOSAGE
....................................................................................................................................................
21
ACTION AND CLINICAL PHARMACOLOGY
.......................................................